Niaspan

How Safe is AbbVie from Niacin’s Woes?

How Safe is AbbVie from Niacin’s Woes?

Motley Fool

Some Experts Defend Niacin For Heart Disease After Failed Study

Some Experts Defend Niacin For Heart Disease After Failed Study

Forbes

Abbott Sues Watson Over Patents for Cholesterol Drug Niaspan

Abbott Sues Watson Over Patents for Cholesterol Drug Niaspan

Bloomberg

Abbott Cholesterol Drug Sales Slip After Study

Abbott Cholesterol Drug Sales Slip After Study

NY Times, NY

Doctors writing fewer prescriptions for Abbott cholesterol drug

Doctors writing fewer prescriptions for Abbott cholesterol drug

Chicago Tribune, IL

Five Lessons From Niaspan’s Disappointing Study

Five Lessons From Niaspan’s Disappointing Study

Forbes

Analysts see lower sales for Abbott's Niaspan

Analysts see lower sales for Abbott's Niaspan

Yahoo/AP

Implications of the Niaspan Study on Abbott and Biosciences

Implications of the Niaspan Study on Abbott and Biosciences

Seeking Alpha

Abbott's Niaspan Setback May Reverberate With Merck

Abbott's Niaspan Setback May Reverberate With Merck

WSJ Online

Abbott Cholesterol Combination Fails to Protect Heart in Study

Abbott Cholesterol Combination Fails to Protect Heart in Study

Bloomberg